Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

564 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
UFO registry: final analysis of baseline data from patients with advanced prostate cancer in Asia.
Ye D, Kanesvaran R, Chiong E, Lojanapiwat B, Pu YS, Rawal SK, Aik OT, Zeng H, Chung BH, Ashani MYN, Ohyama C, Kim CS, Hu Z, Tsai YS, Razack AHA, Singh A, Liu Y, Uemura H. Ye D, et al. Among authors: ohyama c. Ther Adv Med Oncol. 2024 Nov 23;16:17588359241293393. doi: 10.1177/17588359241293393. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39583953 Free PMC article.
Efficacy of valganciclovir prophylaxis in kidney transplant recipients following low-dose rituximab induction therapy: a multicenter retrospective study.
Takehara T, Nishida H, Ichikawa K, Nawano T, Takai S, Fukuhara H, Matsuura T, Maita S, Saito M, Murakami R, Hatakeyama S, Obara W, Saitoh H, Ohyama C, Habuchi T, Watanabe M, Tsuchiya N. Takehara T, et al. Among authors: ohyama c. Clin Exp Nephrol. 2024 Oct 25. doi: 10.1007/s10157-024-02578-4. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 39453573
Prognostic model for second progression-free survival and overall survival in patients with high-risk metastatic hormone-sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy.
Narita S, Yanagisawa T, Hatakeyama S, Hata K, Fujita K, Ueda T, Tanaka T, Maita S, Chiba S, Sato H, Sekine Y, Kobayashi M, Kashima S, Yamamoto R, Numakura K, Saito M, Takayama K, Okane K, Ishida T, Horikawa Y, Kumazawa T, Shimoda J, Iwabuchi I, Suzuki T, Ukimura O, Kimura T, Ohyama C, Nomura K, Habuchi T. Narita S, et al. Among authors: ohyama c. Prostate. 2025 Jan;85(1):73-81. doi: 10.1002/pros.24802. Epub 2024 Sep 30. Prostate. 2025. PMID: 39344365
Long-Term Outcomes of Orthotopic Neobladder Versus Ileal Conduit Urinary Diversion in Robot-Assisted Radical Cystectomy (RARC): Multicenter Results from the Asian RARC Consortium.
Wong CH, Ko IC, Kang SH, Kitamura K, Horie S, Muto S, Ohyama C, Hatakeyama S, Patel M, Yang CK, Kijvikai K, Youl LJ, Chen HG, Zhang RY, Lin TX, Lee LS, Teoh JY, Chan E. Wong CH, et al. Among authors: ohyama c. Ann Surg Oncol. 2024 Sep;31(9):5785-5793. doi: 10.1245/s10434-024-15396-5. Epub 2024 May 27. Ann Surg Oncol. 2024. PMID: 38802711 Free PMC article.
564 results